New Zealand markets closed

Novo Nordisk A/S (NVO)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
101.35-1.03 (-1.01%)
As of 1:01PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close102.38
Bid101.35 x 800
Ask101.37 x 1400
Day's range100.95 - 102.29
52-week range63.22 - 107.24
Avg. volume996,493
Market cap232.121B
Beta (5Y monthly)0.27
PE ratio (TTM)33.39
EPS (TTM)3.04
Earnings dateN/A
Forward dividend & yield1.47 (1.45%)
Ex-dividend date16 Aug 2021
1y target est106.45
  • GlobeNewswire

    Novo Nordisk A/S – Share repurchase programme

    Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 13 September 2021 – On 4 August 2021, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 18 billion to be executed during a 12-month period

  • Motley Fool

    2 Top Healthcare Stocks That Could Boost Your Portfolio in September (and Beyond)

    These two companies have outperformed the market in the past year, and they are likely to continue doing so.

  • Zacks

    Here's Why Novo Nordisk (NVO) is a Strong Growth Stock

    Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.